Fatal donor-derived Kaposi sarcoma following liver transplantation

BMJ Case Rep. 2021 Jun 22;14(6):e236061. doi: 10.1136/bcr-2020-236061.

Abstract

Human herpesvirus-8 (HHV8) is a recognised precursor for a number of neoplastic and non-neoplastic processes. Immunosuppressed recipients of both solid organ and haematopoietic stem cell transplants are at risk of life-threatening lytic reactivations of HHV8-infected B-lymphocytes, primary infections after receiving grafts from HHV8-seropositive donors and more rarely by the direct transplantation of malignant Kaposi sarcoma cells seeded within graft tissue. We describe the case of an HHV8-seronegative patient with confirmed, post-orthotopic liver transplant transmission of HHV8 from a seropositive donor with quantitative evidence of viraemia and subsequent development of disseminated visceral and cutaneous Kaposi sarcoma with a rapidly fatal outcome.

Keywords: gastroenterology; infectious diseases; liver disease; malignant disease and immunosuppression; transplantation.

Publication types

  • Case Reports

MeSH terms

  • Herpesviridae Infections*
  • Herpesvirus 8, Human*
  • Humans
  • Liver Transplantation* / adverse effects
  • Sarcoma, Kaposi* / etiology
  • Tissue Donors
  • Viremia